Invion Ltd has released a press release.
Skin Cancer Trial Moves to BCC With More Encouraging Signals
Earlier from Invion
- Appendix 4D and Half Year Financial Report
- Appendix 4C and Quarterly Activities Report - December 2025
- Major Shareholders Lead Invion $1.3M Capital Raise
- Trading Halt